Physical (in)activity and endothelium-derived constricting factors: Overlooked adaptations

Journal of Physiology

Volumn 586, Issue 2, 2008, Pages 319-324

  Thijssen, D H J ^a   Rongen, G A ^a   Smits, P ^a   Hopman, M T E ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; ENDOTHELIN 1; ENDOTHELIN RECEPTOR ANTAGONIST; PROSTAGLANDIN H2; THROMBOXANE A2; ENDOTHELIUM DERIVED CONSTRICTING FACTOR; PROSTAGLANDIN DERIVATIVE;

AGING; ARTERY BLOOD FLOW; BLOOD VESSEL REACTIVITY; BLOOD VESSEL TONE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR EFFECT; CARDIOVASCULAR RISK; CELL GROWTH; CELL PROLIFERATION; CORONARY ARTERY DISEASE; EXERCISE; HEART FAILURE; HUMAN; LEG BLOOD FLOW; MUSCLE CELL; NONHUMAN; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PULMONARY HYPERTENSION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SIGNAL TRANSDUCTION; TREATMENT DURATION; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; ARTICLE; FITNESS; FUNCTIONAL STATUS; MORPHOLOGICAL ADAPTATION; PHYSICAL INACTIVITY; THERAPY EFFECT;

ANGIOTENSIN II; ANIMALS; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; HUMANS; MOTOR ACTIVITY; THROMBOXANE A2; VASOCONSTRICTION;

EID: 38149062782     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2007.145698     Document Type: Review

References (46)

1. Adams V, Linke A, Krankel N, Erbs S, Gielen S, Mobius-Winkler S, Gummert JF, Mohr FW, Schuler G & Hambrecht R (2005). Impact of regular physical activity on the NAD(P)H oxidase and angiotensin receptor system in patients with coronary artery disease. Circulation 111, 555-562.
2. Amaral SL, Papanek PE & Greene AS (2001). Angiotensin II and VEGF are involved in angiogenesis induced by short-term exercise training. Am J Physiol Heart Circ Physiol 281, H1163-H1169.
3. Asai K, Kudej RK, Takagi G, Kudej AB, Natividad F, Shen YT, Vatner DE & Vatner SF (2001). Paradoxically enhanced endothelin-B receptor-mediated vasoconstriction in conscious old monkeys. Circulation 103, 2382-2386.
4. Barton M, Haudenschild CC, d'Uscio LV, Shaw S, Munter K & Luscher TF (1998). Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice. Proc Natl Acad Sci U S A 95, 14367-14372.
5. Bestle MH, Norsk P & Bie P (2001). Fluid volume and osmoregulation in humans after a week of head-down bed rest. Am J Physiol Regul Integr Comp Physiol 281, R310-R317.
6. Biondi R, Capodicasa E, Tassi C, Mezzasoma L, Benedetti C, Valiani M, Marconi P & Rossi R (1995). Cardiovascular and organ responses and adaptation responses to hypogravity in an experimental animal model. Acta Astronaut 37, 373-377.
7. Bleeker MW, Kooijman M, Rongen GA, Hopman MT & Smits P (2005). Preserved contribution of nitric oxide to baseline vascular tone in deconditioned human skeletal muscle. J Physiol 565, 685-694.
8. Bonnin P, Ben Driss A, Benessiano J, Maillet A, Pavy le Traon A & Levy BI (2001). Enhanced flow-dependent vasodilatation after bed rest, a possible mechanism for orthostatic intolerance in humans. Eur J Appl Physiol 85, 420-426.
9. Braith RW, Welsch MA, Feigenbaum MS, Kluess HA & Pepine CJ (1999). Neuroendocrine activation in heart failure is modified by endurance exercise training. J Am Coll Cardiol 34, 1170-1175.
10. Davidge ST (2001). Prostaglandin H synthase and vascular function. Circ Res 89, 650-660.
11. de Groot PC, Poelkens F, Kooijman M & Hopman MT (2004). Preserved flow-mediated dilation in the inactive legs of spinal cord-injured individuals. Am J Physiol Heart Circ Physiol 287, H374-H380.
12. Donato AJ, Lesniewski LA & Delp MD (2005). The effects of aging and exercise training on endothelin-1 vasoconstrictor responses in rat skeletal muscle arterioles. Cardiovasc Res 66, 393-401.
13. Goligorsky MS, Budzikowski AS, Tsukahara H & Noiri E (1999). Co-operation between endothelin and nitric oxide in promoting endothelial cell migration and angiogenesis. Clin Exp Pharmacol Physiol 26, 269-271.
14. Goodwin AT, Amrani M, Marchbank AJ, Gray CC, Jayakumar J & Yacoub MH (1999). Coronary vasoconstriction to endothelin-1 increases with age before and after ischaemia and reperfusion. Cardiovasc Res 41, 554-562.
15. Goret L, Reboul C, Tanguy S, Dauzat M & Obert P (2005). Training does not affect the alteration in pulmonary artery vasoreactivity in pulmonary hypertensive rats. Eur J Pharmacol 527, 121-128.
16. Green DJ, Maiorana A, O'Driscoll G & Taylor R (2004). Effect of exercise training on endothelium-derived nitric oxide function in humans. J Physiol 561, 1-25.
17. Haruna Y, Bonde-Petersen F, Takenaka K, Suzuki Y, Kawakubo K & Gunji A (1997). Effects of the renin-angiotensinaldosterone system on the cardiovascular system during 20-days bed rest. J Gravit Physiol 4, S62-S68.
18. Haynes WG & Webb DJ (1998). Endothelin as a regulator of cardiovascular function in health and disease. J Hypertens 16, 1081-1098.
19. Hernandez Schulman I, Zhou MS & Raij L (2007). Cross-talk between angiotensin II receptor types 1 and 2: Potential role in vascular remodeling in humans. Hypertension 49, 270-271.
20. Jones AW, Rubin LJ & Magliola L (1999). Endothelin-1 sensitivity of porcine coronary arteries is reduced by exercise training and is gender dependent. J Appl Physiol 87, 1172-1177.
21. Kashimura O, Sakai A & Yanagidaira Y (1995). Effects of exercise-training on hypoxia and angiotensin II-induced pulmonary vasoconstrictions. Acta Physiol Scand 155, 291-295.
22. Kingwell BA, Tran B, Cameron JD, Jennings GL & Dart AM (1996). Enhanced vasodilation to acetylcholine in athletes is associated with lower plasma cholesterol. Am J Physiol Heart Circ Physiol 270, H2008-H2013.
23. Komuro I, Kurihara H, Sugiyama T, Yoshizumi M, Takaku F & Yazaki Y (1988). Endothelin stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle cells. FEBS Lett 238, 249-252.
24. Korzick DH, Muller-Delp JM, Dougherty P, Heaps CL, Bowles DK & Krick KK (2005). Exaggerated coronary vasoreactivity to endothelin-1 in aged rats: Role of protein kinase C. Cardiovasc Res 66, 384-392.
25. Krum H, Louis WJ, Brown DJ & Howes LG (1992). Pressor dose-responses and baroreflex sensitivity in quadriplegic spinal cord injury patients. J Hypertens 10, 245-250.
26. Kubanek M, Malek I, Bytesnik J, Fridl P, Riedlbauchova L, Karasova L, Lanska V & Kautzner J (2006). Decrease in plasma B-type natriuretic peptide early after initiation of cardiac resynchronization therapy predicts clinical improvement at 12 months. Eur J Heart Fail 8, 832-840.
27. Latorre E, Moran M, Aragones MD, Saborido A, Fernandez I, Delgado J, Catalan RE & Megias A (2002). Exercise training-induced changes in sensitivity to endothelin-1 and aortic and cerebellum lipid profile in rats. Lipids 37, 43-52.
28. Liu JL, Irvine S, Reid IA, Patel KP & Zucker IH (2000). Chronic exercise reduces sympathetic nerve activity in rabbits with pacing-induced heart failure: A role for angiotensin II. Circulation 102, 1854-1862.
29. Liu S, Premont RT, Kontos CD, Huang J & Rockey DC (2003). Endothelin-1 activates endothelial cell nitric-oxide synthase via heterotrimeric G-protein βγ subunit signaling to protein jinase B/Akt. J Biol Chem 278, 49929-49935.
30. Maeda S, Miyauchi T, Kakiyama T, Sugawara J, Iemitsu M, Irukayama-Tomobe Y, Murakami H, Kumagai Y, Kuno S & Matsuda M (2001). Effects of exercise training of 8 weeks and detraining on plasma levels of endothelium-derived factors, endothelin-1 and nitric oxide, in healthy young humans. Life Sci 69, 1005-1016.
31. Meck JV, Waters WW, Ziegler MG, deBlock HF, Mills PJ, Robertson D & Huang PL (2004). Mechanisms of postspaceflight orthostatic hypotension: low α1-adrenergic receptor responses before flight and central autonomic dysregulation postflight. Am J Physiol Heart Circ Physiol 286, H1486-H1495.
32. 1 receptor regulation. Circulation 105, 530-536.
33. Oates JA, FitzGerald GA, Branch RA, Jackson EK, Knapp HR & Roberts LJ 2nd (1988). Clinical implications of prostaglandin and thromboxane A2 formation (1). N Engl J Med 319, 689-698.
34. Pinaud F, Bocquet A, Dumont O, Retailleau K, Baufreton C, Andriantsitohaina R, Loufrani L & Henrion D (2007). Paradoxical role of angiotensin II type 2 receptors in resistance arteries of old rats. Hypertension 50, 96-102.
35. Robergs RA, Appenzeller O, Qualls C, Aisenbrey J, Krauss J, Kopriva L & DePaepe J (1993). Increased endothelin and creatine kinase after electrical stimulation of paraplegic muscle. J Appl Physiol 75, 2400-2405.
36. Spieker LE, Flammer AJ & Luscher TF (2006). The vascular endothelium in hypertension. Handb Exp Pharmacol 176, 249-283.
37. Symons JD, Rendig SV, Stebbins CL & Longhurst JC (2000). Microvascular and myocardial contractile responses to ischemia: influence of exercise training. J Appl Physiol 88, 433-442.
38. Tank JE, Vora JP, Houghton DC & Anderson S (1994). Altered renal vascular responses in the aging rat kidney. Am J Physiol Renal Physiol 266, F942-F948.
39. Thijssen DH, Ellenkamp R, Kooijman M, Pickkers P, Rongen GA, Hopman MT & Smits P (2007a). A causal role for endothelin-1 in the vascular adaptation to skeletal muscle deconditioning in spinal cord injury. Arterioscler Thromb Vasc Biol 27, 325-331.
40. Thijssen DH, Hopman MT & Levine BD (2007b). Endothelin and aged blood vessels: One more reason to get off the couch? Hypertension 50, 292-293.
41. Thijssen DH, Rongen GA, van Dijk A, Smits P & Hopman MT (2007c). Enhanced endothelin-1-mediated leg vascular tone in healthy older subjects. J Appl Physiol 103, 852-857.
42. Van Guilder GP, Westby CM, Greiner JJ, Stauffer BL & DeSouza CA (2007). Endothelin-1 vasoconstrictor tone increases with age in healthy men but can be reduced by regular aerobic exercise. Hypertension 50, 403-409.
43. 2+ signaling. Am J Physiol Heart Circ Physiol 283, H2397-H2410.
44. Wannamethee SG & Shaper AG (2001). Physical activity in the prevention of cardiovascular disease: An epidemiological perspective. Sports Med 31, 101-114.
45. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K & Masaki T (1988). A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332, 411-415.
46. Zucker IH, Patel KP, Schultz HD, Li YF, Wang W & Pliquett RU (2004). Exercise training and sympathetic regulation in experimental heart failure. Exerc Sport Sci Rev 32, 107-111.